LAVA Therapeutics (LVTX) Earnings Date & Reports

LAVA Therapeutics NV isa clinical stage immuno-oncology company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LVTX is expected to report earnings to rise 126.21% to -31 cents per share on May 14

LAVA Therapeutics LVTX Stock Earnings Reports

Q1'25

Est.

$-0.32

Q4'24

Beat

by $0.16

Q3'24

Missed

by $0.13

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.29

The last earnings report on March 28 showed earnings per share of -14 cents, beating the estimate of -30 cents. With 6.06K shares outstanding, the current market capitalization sits at 35.25M.

View a ticker or compare two or three

Compare

LVTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LVTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Yalelaan 62

Phone

+31 850163100

Employees

Web

https://www.lavatherapeutics.com